Pinnacle Wealth Planning Services’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.2K Buy
2,822
+325
+13% +$3.14K ﹤0.01% 1410
2026
Q1
$18.5K Sell
2,497
-95
-4% -$1K ﹤0.01% 1728
2025
Q4
$30.5K Buy
+2,592
New +$28K ﹤0.01% 1506
2022
Q4
Sell
-10,089
Closed -$87K 478
2022
Q3
$87K Buy
+10,089
New +$100K 0.02% 377
2021
Q1
Sell
-1,383
Closed -$74K 1371
2020
Q4
$74K Buy
+1,383
New +$62.5K 0.02% 613

Other funds holding NEO

Pinnacle Wealth Planning Services's NEO Position: Q2 2026 in Review

Pinnacle Wealth Planning Services increased its NeoGenomics (NEO) stake by 13% in Q2 2026, buying an estimated $3.14K and bringing the position to 2,822 shares worth $41.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1410.

Pinnacle Wealth Planning Services first reported a position in NEO in Q4 2020 and has held it in 5 quarters since. The position peaked at $87K in Q3 2022. 267 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Pinnacle Wealth Planning Services held 2,822 shares of NeoGenomics worth $41.2K as of Q2 2026.
  • Pinnacle Wealth Planning Services bought 325 NeoGenomics shares in Q2 2026, an estimated $3.14K.
  • NeoGenomics made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #1410 holding.
  • Pinnacle Wealth Planning Services first reported a position in NeoGenomics in Q4 2020 and has held it in 5 quarters since.
  • Pinnacle Wealth Planning Services's NeoGenomics position peaked at $87K in Q3 2022.
  • 267 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.